ATM and cancer: While cancer cells are continuously cycling, that the reduced phosphorylation of Artemis via ATM inhibition has little effect on viability and hairpin opening in these B cells points to NHEJ factors like DNA-PKcs and Artemis as being the more critical targets in blocking DNA repair in blood cancer treatments that rely on overloading cells with DSBs.